(Q51528452)

6 April 2018

title

Prognostic impact of MYCN, DDX1, TrkA, and TrkC gene transcripts expression in neuroblastoma. (English)

1 reference

6 April 2018

author

Israel Bendit

6

1 reference

6 April 2018

Sabri Saeed Sanabani

object named as

Sabri Saeed Sanabani

2

0 references

author name string

Daniela Raguer Valadão de Souza

1

1 reference

6 April 2018

Ana Carolina Mamana Fernandes de Souza

3

1 reference

6 April 2018

Vicente Filho Odone

4

1 reference

6 April 2018

Sidnei Epelman

5

1 reference

6 April 2018

publication date

9 December 2010

1 reference

6 April 2018

published in

Pediatric Blood Cancer

1 reference

6 April 2018

volume

56

1 reference

6 April 2018

issue

5

1 reference

6 April 2018

page(s)

749-756

1 reference

6 April 2018

Molecular basis for heterogeneity in human neuroblastomas

cites work

1 reference

21 January 2018

1 reference

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

21 January 2018

1 reference

Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study

21 January 2018

1 reference

Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma

21 January 2018

1 reference

Prognostic value of MYCN and ID2 overexpression in neuroblastoma.

21 January 2018

1 reference

Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival

21 January 2018

1 reference

Trk receptor tyrosine kinases: a bridge between cancer and neural development

21 January 2018

1 reference

Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis

21 January 2018

1 reference

Expression and function of TRK-B and BDNF in human neuroblastomas

21 January 2018

1 reference

Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma

21 January 2018

1 reference

Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma.

21 January 2018

1 reference

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma

21 January 2018

1 reference

Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas.

21 January 2018

1 reference

Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling.

21 January 2018

1 reference

High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma

21 January 2018

1 reference

High level MycN expression in non-MYCN amplified neuroblastoma is induced by the combination treatment nutlin-3 and doxorubicin and enhances chemosensitivity

21 January 2018

1 reference

MycN sensitizes neuroblastoma cells for drug-induced apoptosis

21 January 2018

1 reference

MycN sensitizes neuroblastoma cells for drug-triggered apoptosis

21 January 2018

1 reference

Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas

21 January 2018

1 reference

Molecular characterization and classification of neuroblastoma

21 January 2018

1 reference

Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas

21 January 2018

1 reference

Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma

21 January 2018

1 reference

Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay.

21 January 2018

1 reference

Identification of the neuroblastoma-amplified gene product as a component of the syntaxin 18 complex implicated in Golgi-to-endoplasmic reticulum retrograde transport

21 January 2018

1 reference

Expression of trkA cDNA in neuroblastomas mediates differentiation in vitro and in vivo

21 January 2018

1 reference

TrkA induces apoptosis of neuroblastoma cells and does so via a p53-dependent mechanism

21 January 2018

1 reference

Customized Oligonucleotide Microarray Gene Expression–Based Classification of Neuroblastoma Patients Outperforms Current Clinical Risk Stratification

21 January 2018

1 reference

Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease

21 January 2018

1 reference

No Evidence for Correlation of DDX1 Gene Amplification With Improved Survival Probability in Patients With MYCN-Amplified Neuroblastomas

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PBC.22823

1 reference

6 April 2018

PubMed ID

21154590

1 reference

6 April 2018